ENOV saw its Momentum Indicator move below the 0 level on November 19, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned negative. In 66 of the 82 cases, the stock moved further down in the following days. The odds of a decline are at 80%.
The 10-day RSI Indicator for ENOV moved out of overbought territory on November 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 18 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 69%.
The Moving Average Convergence Divergence Histogram (MACD) for ENOV turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 35 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENOV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
ENOV broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
ENOV moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ENOV crossed bullishly above the 50-day moving average on October 27, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 59%.
Following a +1.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where ENOV advanced for three days, in 156 of 251 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
The Aroon Indicator entered an Uptrend today. In 99 of 182 cases where ENOV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 54%.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. ENOV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 49 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 72 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.060) is normal, around the industry mean (4.142). P/E Ratio (-1.407) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (3.441) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.466) is also within normal values, averaging (40.124).
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENOV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
OFIX saw its Momentum Indicator move below the 0 level on October 30, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned negative. In 71 of the 86 cases, the stock moved further down in the following days. The odds of a decline are at 83%.
The Moving Average Convergence Divergence Histogram (MACD) for OFIX turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 42 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.
OFIX moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for OFIX crossed bearishly below the 50-day moving average on November 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 18 of 22 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 82%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OFIX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +11.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where OFIX advanced for three days, in 202 of 285 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
OFIX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 111 of 149 cases where OFIX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. OFIX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.747) is normal, around the industry mean (4.142). P/E Ratio (-5.178) is within average values for comparable stocks, (3.291). OFIX's Projected Growth (PEG Ratio) (48.825) is slightly higher than the industry average of (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.431) is also within normal values, averaging (40.124).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OFIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ENOV | OFIX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 97 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 72 Overvalued | 98 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 94 | |
PRICE GROWTH RATING 1..100 | 40 | 85 | |
P/E GROWTH RATING 1..100 | 49 | 15 | |
SEASONALITY SCORE 1..100 | 50 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ENOV's Valuation (72) in the Industrial Machinery industry is in the same range as OFIX (98) in the Medical Specialties industry. This means that ENOV’s stock grew similarly to OFIX’s over the last 12 months.
ENOV's Profit vs Risk Rating (100) in the Industrial Machinery industry is in the same range as OFIX (100) in the Medical Specialties industry. This means that ENOV’s stock grew similarly to OFIX’s over the last 12 months.
OFIX's SMR Rating (94) in the Medical Specialties industry is in the same range as ENOV (98) in the Industrial Machinery industry. This means that OFIX’s stock grew similarly to ENOV’s over the last 12 months.
ENOV's Price Growth Rating (40) in the Industrial Machinery industry is somewhat better than the same rating for OFIX (85) in the Medical Specialties industry. This means that ENOV’s stock grew somewhat faster than OFIX’s over the last 12 months.
OFIX's P/E Growth Rating (15) in the Medical Specialties industry is somewhat better than the same rating for ENOV (49) in the Industrial Machinery industry. This means that OFIX’s stock grew somewhat faster than ENOV’s over the last 12 months.
| ENOV | OFIX | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 69% | 2 days ago 69% |
| Stochastic ODDS (%) | 2 days ago 57% | 2 days ago 68% |
| Momentum ODDS (%) | 2 days ago 80% | 2 days ago 83% |
| MACD ODDS (%) | 2 days ago 80% | 2 days ago 79% |
| TrendWeek ODDS (%) | 2 days ago 80% | 2 days ago 78% |
| TrendMonth ODDS (%) | 2 days ago 63% | 2 days ago 75% |
| Advances ODDS (%) | 6 days ago 62% | 18 days ago 71% |
| Declines ODDS (%) | 2 days ago 79% | 2 days ago 80% |
| BollingerBands ODDS (%) | 2 days ago 80% | 2 days ago 68% |
| Aroon ODDS (%) | 2 days ago 54% | 2 days ago 74% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ENOV’s FA Score shows that 0 FA rating(s) are green while OFIX’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ENOV’s TA Score shows that 5 TA indicator(s) are bullish while OFIX’s TA Score has 5 bullish TA indicator(s).
ENOV (@Medical/Nursing Services) experienced а -7.98% price change this week, while OFIX (@Medical/Nursing Services) price change was -15.34% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -11.44%. For the same industry, the average monthly price growth was -15.18%, and the average quarterly price growth was -18.29%.
ENOV is expected to report earnings on Feb 25, 2027.
OFIX is expected to report earnings on Feb 19, 2027.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, ENOV has been loosely correlated with FELE. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ENOV jumps, then FELE could also see price increases.
| Ticker / NAME | Correlation To ENOV | 1D Price Change % | ||
|---|---|---|---|---|
| ENOV | 100% | -2.90% | ||
| FELE - ENOV | 56% Loosely correlated | -2.75% | ||
| DOV - ENOV | 55% Loosely correlated | -2.81% | ||
| PH - ENOV | 53% Loosely correlated | -3.78% | ||
| ITT - ENOV | 52% Loosely correlated | -2.51% | ||
| ZBH - ENOV | 52% Loosely correlated | -0.36% | ||
More | ||||
A.I.dvisor indicates that over the last year, OFIX has been loosely correlated with SYK. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if OFIX jumps, then SYK could also see price increases.
| Ticker / NAME | Correlation To OFIX | 1D Price Change % | ||
|---|---|---|---|---|
| OFIX | 100% | -4.26% | ||
| SYK - OFIX | 50% Loosely correlated | -0.98% | ||
| ENOV - OFIX | 48% Loosely correlated | -2.90% | ||
| PODD - OFIX | 48% Loosely correlated | -2.96% | ||
| ATEC - OFIX | 47% Loosely correlated | -3.19% | ||
| SIBN - OFIX | 46% Loosely correlated | -0.08% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LOCT | 23.20 | -0.28 | -1.18% |
| Innovator Premium Income 15 Buffer ETF - October (LOCT) | |||
| TBLU | 50.48 | -0.63 | -1.24% |
| Tortoise Global Water ETF (TBLU) | |||
| SEIQ | 40.26 | -1.02 | -2.47% |
| SEI Enhanced U.S. Large Cap Quality Factor ETF (SEIQ) | |||
| BDEC | 50.08 | -1.40 | -2.72% |
| Innovator U.S. Equity Buffer ETF - December (BDEC) | |||
| OEF | 337.21 | -14.43 | -4.10% |
| iShares S&P 100 ETF (OEF) | |||